Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 66999-64-2 | MDL No. : | MFCD28040750 |
Formula : | C6H3BrClN3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BUCCMVKMXZJZPJ-UHFFFAOYSA-N |
M.W : | 232.47 | Pubchem ID : | 324434 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 45.7 |
TPSA : | 30.19 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.47 cm/s |
Log Po/w (iLOGP) : | 1.81 |
Log Po/w (XLOGP3) : | 3.16 |
Log Po/w (WLOGP) : | 2.15 |
Log Po/w (MLOGP) : | 2.35 |
Log Po/w (SILICOS-IT) : | 1.8 |
Consensus Log Po/w : | 2.25 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.88 |
Solubility : | 0.0308 mg/ml ; 0.000133 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.46 |
Solubility : | 0.0798 mg/ml ; 0.000343 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.19 |
Solubility : | 0.15 mg/ml ; 0.000647 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.07 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 4922-68-3 ]
3-Bromo[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.83
[ 832735-60-1 ]
7-Bromo-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.62
[ 108281-79-4 ]
6-Bromo-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.62
[ 1190927-76-4 ]
7-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.61
[ 54230-90-9 ]
8-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.58
[ 27187-13-9 ]
5-Chloro-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.83
[ 66999-59-5 ]
5-Chloro-3-methyl-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.82
[ 501357-89-7 ]
8-Chloro[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.63
[ 3931-68-8 ]
5-Chloroimidazo[1,2-a]pyridine hydrochloride
Similarity: 0.57
[ 342613-67-6 ]
3-Bromo-7-chloroimidazo[1,2-a]pyridine
Similarity: 0.54
[ 27187-13-9 ]
5-Chloro-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.83
[ 4922-68-3 ]
3-Bromo[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.83
[ 66999-59-5 ]
5-Chloro-3-methyl-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.82
[ 1004-65-5 ]
3-Methyl-[1,2,4]triazolo[4,3-a]pyridine
Similarity: 0.65
[ 1598386-14-1 ]
[1,2,4]Triazolo[4,3-a]pyridin-7-amine hydrochloride
Similarity: 0.63